Data as of Mar 07
| +2.20 / +8.60%|
The 3 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 30.00, with a high estimate of 35.00 and a low estimate of 29.00. The median estimate represents a +8.03% increase from the last price of 27.77.
The current consensus among 3 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.